U.S. markets closed

PPD, Inc. (PPD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.76-0.09 (-0.19%)
At close: 4:00PM EDT
46.75 -0.01 (-0.02%)
After hours: 04:11PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close46.85
Open46.90
Bid46.77 x 800
Ask46.81 x 3200
Day's Range46.73 - 46.93
52 Week Range31.54 - 46.99
Volume1,614,941
Avg. Volume1,332,653
Market Cap16.427B
Beta (5Y Monthly)N/A
PE Ratio (TTM)65.31
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
1% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PPD, Inc.
    Analyst Report: PPD, Inc.PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
All
News
Press Releases